Side Effects

In LUME-Lung 1, adverse events with VARGATEF® plus docetaxel were generally manageable1


The most common adverse events with VARGATEF® + docetaxel were:


AEs reported in ≥ 10% of adenocarcinoma patients in LUME-lung 12

 

AEs reported in ≥ 10% of adenocarcinoma patients in LUME-lung 1

AE = adverse event;

ALT = alanine aminotransferase;

AST = aspartate aminotransferase;

WBC = white blood cell

 

Adverse events were classified according to Common Terminology Criteria for Adverse Events version 3.0.



References

1
Reck M et al. Lancet Oncol 2014; 15:143–55.
2
Reck M et al. Lancet Oncol 2014; supplement published online January 9. http://dx.doi. org/10.1016/S1470-2045(13)70586-2.